ArticleCancer research2016

CRISPR/Cas9-Mediated Trp53 and Brca2 Knockout to Generate Improved Murine Models of Ovarian High-Grade Serous Carcinoma.

Josephine Walton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.